Delivery Order SPE2DB22D7058-SPE2DB26FSUA5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Isosorbide Mononitrate 120 mg tablets (100-count unit) with a ceiling value of $1,384.36. This is a firm fixed-price delivery order executed under a non-competitive set-aside arrangement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and...
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,067.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Isosorbide Mononitrate 20 mg, a cardiovascular medication used to treat angina. The contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) valued at $1,128.63. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of isosorbide dinitrate 40 mg tablets in 100-count bottles. The $13,462.47 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,549.38 firm fixed-price delivery order is for Isosorbide Dinitrate 40 mg tablets. The contract has a completion date of July 5, 2024 and does not utilize any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The federal contract award SPE2DB22D7058|SPE2DB24FSXN2 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $7,495.65 firm-fixed-price delivery order is for the supply of 4,565,703,493 units of Isosorbide Dinitrate 40 mg tablets. This contract is not set aside and has an ultimate completion date of September 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal...
- SPE2DB22D7058Indefinite Delivery Contract
- SPE2DB22D7058-SPE2DB26FSUA5Delivery Order
The Defense Logistics Agency awarded a $2,768.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Isosorbide Dinitrate 40 mg tablets (100-count) on October 28, 2025, with an ultimate completion date of October 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company supplies a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This particular delivery order for cardiovascular medication reflects the company's ongoing role in fulfilling the Defense Health Agency's pharmaceutical procurement requirements through the broader DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/28/25 |